top of page

Screenshot 2023-02-16 at 3.00_edited.png

Search

ResolutionRx
- Aug 25, 2023
- 1 min read

ResolutionRX Releases Automated Slide Deck

View or download the Automated Version of our slide deck below.

Recent Posts

Our Parent Company, RespireRx Pharmaceuticals Inc., Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Improve Bladder Function in Patients with Spinal Cord Injury

RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and...

Our Parent Company, RespireRx Pharmaceuticals Inc., Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine

Glen Rock, N.J., February 13, 2024 /Globe Newswire - RespireRx Pharmaceuticals Inc. (OTC Pink Market: RSPI) (“RespireRx” or the...

Our Parent Company, RespireRx Pharmaceuticals Inc., Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors

Glen Rock, N.J., January 22, 2024 /Globe Newswire – RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”),...

Comments

Contact

Jeff E. Margolis

Acting CO-CEO, CFO,

Director

0011+1+917-834-7206

jmargolis@resolutionrx.com.au

Subscribe

Sign up for our mailing list to receive updates

Quick Links

bottom of page